• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    7/1/24 6:05:25 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary
    Get the next $RCM alert in real time by email
    SC 13D/A 1 d857163dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 7)*

     

     

    R1 RCM Inc.

    (Name of Issuer)

    Common stock, par value $0.01 per share

    (Title of Class of Securities)

    77634L 105

    (CUSIP Number)

    New Mountain Capital, L.L.C.

    1633 Broadway, 48th Floor

    New York, New York 10019

    (212) 720-0300

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    July 1, 2024

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 77634L 105   Schedule 13D   Page 2 of 14

     

     (1)    

     Names of reporting persons

     

     CoyCo 1, L.P.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     124,910,408

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     124,910,408

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     124,910,408

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     29.7%*

    (14)  

     Type of reporting person (see instructions)

     

     PN

     

    *

    Based on 421,255,230 shares of common stock (the “Common Stock”) of R1 RCM Inc. (the “Issuer”) outstanding as of May 6, 2024, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2024 (the “Form 10-Q”).


    CUSIP No. 77634L 105   Schedule 13D   Page 3 of 14

     

     (1)    

     Names of reporting persons

     

     CoyCo 2, L.P.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     11,075,180

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     11,075,180

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     11,075,180

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     2.6%*

    (14)  

     Type of reporting person (see instructions)

     

     PN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 4 of 14

     

     (1)    

     Names of reporting persons

     

     CoyCo GP, L.L.C.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 5 of 14

     

     (1)    

     Names of reporting persons

     

     New Mountain Partners V (AIV-D), L.P.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     PN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 6 of 14

     

     (1)    

     Names of reporting persons

     

     New Mountain Investments V, L.L.C.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 7 of 14

     

     (1)    

     Names of reporting persons

     

     New Mountain Capital, L.L.C.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 8 of 14

     

     (1)    

     Names of reporting persons

     

     New Mountain Capital Group, L.P.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     PN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 9 of 14

     

     (1)    

     Names of reporting persons

     

     NM Holdings GP, L.L.C.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 10 of 14

     

     (1)    

     Names of reporting persons

     

     Steven B. Klinsky

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     United States of America

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)     

     Sole voting power

     

     0

        (8)   

     Shared voting power

     

     135,985,588

        (9)   

     Sole dispositive power

     

     0

       (10)   

     Shared dispositive power

     

     135,985,588

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     135,985,588

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     32.3%*

    (14)  

     Type of reporting person (see instructions)

     

     IN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105   Schedule 13D   Page 11 of 14

     

    This Amendment No. 7 (the “Amendment”) amends and supplements the Schedule 13D filed by the Reporting Persons on July 1, 2022, as amended on October 3, 2023, February 7, 2024, February 26, 2024, April 29, 2024, May 7, 2024 and June 14, 2024 (collectively, the “Original Schedule 13D” and, as amended and supplemented by this Amendment, this “Statement”), with respect to the Common Stock. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Original Schedule 13D.

    Item 3. Source and Amount of Funds or Other Consideration

    Item 3 of the Original Schedule 13D is amended and restated in its entirety as follows:

    The Reporting Persons and their affiliates intend to fund the transactions contemplated by the Updated Draft Proposal (described below) through proceeds of (i) debt financing from Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC and (ii) equity financing funded by the rollover of the Investors’ existing ownership interest in the Company and new cash equity to be provided or arranged by New Mountain Capital, L.L.C. and certain managed funds.

    Item 4. Purpose of Transaction.

    Item 4 of the Original Schedule 13D is amended and supplemented by adding the following:

    In accordance with the terms of June 12 Waiver Request previously granted by the Issuer, representatives of New Mountain Capital, L.L.C. and TCP-ASC have engaged in discussions and mutual due diligence with respect to a potential joint acquisition of the shares of the Company not owned by such parties or their affiliates. These discussions have not resulted in any agreement to date, and New Mountain Capital, L.L.C. is no longer interested in pursuing a joint proposal with TCP-ASC.

    New Mountain Capital, L.L.C. continues to believe that it is in the best interests of the Issuer, its customers and employees and the unaffiliated stockholders to accelerate a process whereby the board of directors of the Issuer can pursue a “take-private” transaction with affiliates of New Mountain Capital, L.L.C. (a “Potential Transaction”). Therefore, on July 1, 2024, the Investors submitted a new request to the Issuer for a waiver of the standstill restrictions contained in the Investor Rights Agreement in order to permit one or more affiliates of the Investors to make a proposal to acquire all of the outstanding shares of the Issuer’s Common Stock not owned by the Investors and requested a response from the Issuer by no later than 5:00 p.m. ET on July 3, 2024 (the “July 1 Waiver Request”). The July 1 Waiver Request attached an updated form of proposal which included, among other things, a proposed purchase price of $13.25 per share in cash (the “Updated Draft Proposal”). As described in the Updated Draft Proposal, New Mountain Capital, L.L.C. is open to having TowerBrook Capital Partners and Ascension Health participate in a Potential Transaction as equity co-investors.

    The Reporting Persons and their affiliates are engaged in ongoing discussions and negotiations with existing stockholders. The Reporting Persons and their affiliates have not reached any agreement, arrangement or understanding with any person (other than Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC with respect to potential financing of a Potential Transaction) regarding a Potential Transaction. Accordingly, the Reporting Persons disclaim the formation of any group at this time.

    No assurances can be given that a definitive agreement will be reached or that a Potential Transaction will be consummated. The Reporting Persons and their affiliates reserve the right to modify the Updated Draft Proposal at any time. Subject to the restrictions set forth in the Investor Rights Agreement, as modified by the January 26 Waiver Request, the February 26 Waiver Request, the June 12 Waiver Request and the July 1 Waiver Request, the Reporting Persons and their affiliates reserve the right to formulate other plans or make other proposals which could result in one or more of the transactions, events or actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, and to modify or withdraw any such plan or proposal at any time. Subject to the restrictions set forth in the Investor Rights Agreement, as modified by January 26 Waiver Request, the February 26 Waiver Request, the June 12 Waiver Request and the July 1 Waiver Request, if a Potential Transaction is not consummated, the Reporting Persons and their affiliates will continue to regularly review and assess their investment in the Issuer and, depending on market conditions and other factors, may determine, from time to time, to engage in any of the events set forth in clauses (a) through (j) of Item 4 of Schedule 13D.


    CUSIP No. 77634L 105   Schedule 13D   Page 12 of 14

     

    The foregoing descriptions of the July 1 Waiver Request and the Updated Draft Proposal do not purport to be complete and are subject to, and qualified in their entirety by, reference to the full text of the July 1 Waiver Request, which is attached hereto as Exhibit 8.

    Item 5. Interest in Securities of the Issuer.

    Item 5 of the Original Schedule 13D is amended and restated in its entirety as follows:

    The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Statement and the information set forth or incorporated in Items 2, 3, 4 and 6 is incorporated by reference in its entirety into this Item 5.

    (a) and (b) The percentages in this Item 5 and in other provisions of this Statement relating to beneficial ownership of Common Stock are based on based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.

    (c) None of the Reporting Persons has effected any transaction in the shares of Common Stock during the past 60 days.

    (d) No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.

    (e) Not applicable.

    Item 7. Materials to be Filed as Exhibits.

    Item 7 of the Original Schedule 13D is amended and supplemented by adding the following:

     

    Exhibit
    Number
      

    Description of Exhibit

    8.    July 1 Waiver Request.


    CUSIP No. 77634L 105   Schedule 13D   Page 13 of 14

     

    Signatures

    After reasonable inquiry and to the best knowledge and belief of the undersigned, such person certifies that the information set forth in this Statement with respect to such person is true, complete and correct.

    Dated: July 1, 2024

     

      CoyCo 1, L.P.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Vice President
      CoyCo 2, L.P.; By its General Partner CoyCo GP, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Vice President
      CoyCo GP, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Vice President
      New Mountain Partners V (AIV-D), L.P.; By its General Partner New Mountain Investments V, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Authorized Signatory
      New Mountain Investments V, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Authorized Signatory
      New Mountain Capital, L.L.C.; By its Managing Member New Mountain Capital Group, L.P.; By its General Partner NM Holdings GP, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Authorized Signatory
      New Mountain Capital Group, L.P.; By its General Partner NM Holdings GP, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Authorized Signatory


    CUSIP No. 77634L 105   Schedule 13D   Page 14 of 14

     

      NM Holdings GP, L.L.C.
    By:  

    /s/ Adam B. Weinstein

      Name: Adam B. Weinstein
      Title: Authorized Signatory
    Steven B. Klinsky
     

    /s/ Steven B. Klinsky

    Get the next $RCM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RCM

    DatePrice TargetRatingAnalyst
    8/8/2024Overweight → Equal-Weight
    Morgan Stanley
    8/1/2024Overweight → Equal-Weight
    Stephens
    8/1/2024Outperform → Market Perform
    Leerink Partners
    8/1/2024Buy → Hold
    Jefferies
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    3/20/2024$16.00Neutral → Buy
    Citigroup
    2/26/2024$14.00Outperform
    Leerink Partners
    1/3/2024$14.00Overweight
    Barclays
    More analyst ratings

    $RCM
    Financials

    Live finance-specific insights

    See more
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM Reports Second Quarter 2024 Results

      MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period last year.Adjusted EBITDA of $156.1 million, compared to adjusted EBITDA of $142.9 million in the same period last year. The quarte

      8/7/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

      MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.

      8/1/24 7:30:34 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/22/24 4:06:56 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/19/24 4:36:38 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      8/5/24 7:31:56 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    SEC Filings

    See more
    • SEC Form POSASR filed by R1 RCM Inc.

      POSASR - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:26:18 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:18:28 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:17:27 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • TowerBrook and CD&R Complete Acquisition of R1 RCM

      MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1"), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners ("TowerBrook") and Clayton, Dubilier & Rice ("CD&R") have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1's common stock has ceased trading and w

      11/19/24 9:06:28 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/22/24 4:05:14 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:37:21 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:35:59 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • R1 RCM downgraded by Morgan Stanley

      Morgan Stanley downgraded R1 RCM from Overweight to Equal-Weight

      8/8/24 8:58:18 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Stephens

      Stephens downgraded R1 RCM from Overweight to Equal-Weight

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Leerink Partners

      Leerink Partners downgraded R1 RCM from Outperform to Market Perform

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Leadership Updates

    Live Leadership Updates

    See more
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • James Hardie Industries Announces Global Leadership Appointment

      Rachel Wilson appointed as Chief Financial Officer (CFO) James Hardie Industries plc ((ASX: JHX, NYSE:JHX), the world's #1 producer and marketer of high-performance fiber cement and fiber gypsum building solutions, today announced the appointment of Ms. Rachel Wilson as Chief Financial Officer, effective immediately. As a member of the global executive team, Ms. Wilson will report directly to Chief Executive Officer Aaron Erter. Ms. Wilson was appointed after Jason Miele stepped down as Chief Financial Officer. Mr. Miele will remain with the Company for three months as an advisor to the Chief Executive Officer for special projects and will thereafter depart the organization. "I would li

      8/16/23 9:50:00 PM ET
      $JHX
      $RCM
      Building Materials
      Industrials
      Other Consumer Services
      Consumer Discretionary
    • R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors

      MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Trelian

      8/12/21 8:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary